Two needles 600 yuan, the domestic new crown vaccine pricing out, the global vaccine price in China ranked no.

Core feed 1. Domestic two new coronavirus inactivated vaccine prices, one shot 300 yuan, two needles 600 yuan.
more than 100,000 high-risk groups have been vaccinated, no cases of obvious adverse reactions, no one infected.
. It is not accurate to say that the new crown vaccine in the United States will be free.
, Pfizer and partner BioNTech (Germany) announced that they had reached a pre-purchase agreement with the U.S. government.
but the government pays only wholesale prices, and it is not known whether there will be additional prices for vaccine shipments, storage and injections.
3. It should be pointed out that the current vaccines of the United States, Britain and Russia are not inactivated vaccines, RNA vaccines and adenovirus vaccines, the production process does not require new coronavirus.
and China's inactivated vaccine production process is more complex, production costs and the cost of maintaining biosecurity are higher than other vaccines.
china's current demand for vaccines, the solution to the vaccine price problem in addition to the national shot, can also be "wait."
now give vaccine companies more flexibility to commercially price vaccines at reasonable prices to more urgently needed international markets, while some of the country's most in-need people can inject them at their own expense.
two new coronavirus inactivated vaccine prices, one shot 300 yuan, two needles 600 yuan, pricing basis? More than 100,000 high-risk people have been vaccinated on September 22, Hong Kong's South China Morning Post reported that China's two inactivated vaccines are applying for conditional approval by the drug regulatory authorities, once approved, the maximum price of the vaccine is 600 yuan ($88).
the current two inactivated vaccines, both need to be vaccinated two injections, the price of each needle is 300 yuan.
inactivated vaccine, which has been urgently provided to some state-owned enterprises, as well as high-risk groups for voluntary use, many overseas workers, diplomats and front-line medical personnel to carry out the fight.
has been vaccinated hundreds of thousands of times, no obvious adverse reactions, no one infected, including after the vaccine to overseas high-risk countries and regions tens of thousands of people, so far achieved zero infection.
two vaccines, all of which entered phase III trials in July, are expected to be available by the end of December.
, chairman of the Company, has revealed that a dose of vaccine is 4 micrograms, protection rate of 100%, need 2 stitches, the price should be less than 1000 yuan.
2 needles less than 1000 yuan of the argument caused internet debate, because the price exceeded many people's expectations.
media have been priced at 1000 yuan, calculating the current income of 100,000 emergency vaccinators, is already a staggering figure.
Huichuan, vice president of China Biotechnology Co., Ltd., a pharmaceutical group, responded to the vaccine pricing issue.
said the product was not priced until it went on sale, but would take into account its access, safety, effectiveness and people's ability to pay to determine its price.
that the final pricing of vaccines is not in the hands of vaccine research and development companies, and that government regulators will step in.
Zhongwei, head of the special working group on vaccine research and development of the joint prevention and control mechanism of the State Council, has made it clear that the new coronavirus vaccine is a public health product and can only be priced on cost.
vaccine prices will not be affected by conventional market supply and demand, the final price is certainly lower than the above statement.
currently 300 yuan per needle, two needles 600 yuan, may be the comprehensive cost of the National Pharmaceutical Group and the ability of the public to accept, given a basic price.
but the pharmaceutical group did not disclose the basis of pricing and considerations.
300 yuan a needle, is it expensive? It depends on the point of view of the problem.
the world's new crown confirmed more than 30 million people, nearly 1 million deaths, the end of the epidemic is far from over.
China's vaccine companies were proud to be able to advance clinical research on vaccines to Phase III trials in the first place, and it is likely to be the first in the world to obtain the results of Phase III trials;
So, China's new crown vaccine is an achievement, and the reason for this achievement is not only the vaccine companies on vaccine research and development, production, clinical trials, the research institutes before the separation, access to the new crown virus strain efforts are also to be credited.
if it turns out that vaccines can protect vaccinators from the virus, it's too cheap to get 300 yuan a shot, " he said.
To take influenza vaccine as an example, in Beijing, the most expensive self-costed influenza vaccine this year is the influenza virus sub-unit vaccine, 168 yuan each, the general three-price adult influenza vaccine winning price is 40 to 50 yuan.
use this as a reference, the price of vaccines is obviously a little more expensive.
South China Morning Post also reported that compared with the pricing of six other new U.S. and European crown vaccines currently in Phase III clinical trials, it appears that this pricing is ahead of other vaccines.
price of two needles 600 yuan, but also to consider the actual situation of vaccination, it is reported that there are still "hundreds of millions of low- and middle-income people and below, their average monthly income is about 1000 yuan."
1000 yuan here should be a median, not all of these people's monthly income is below 1000 yuan, but it is certain that if you want to get vaccinated it will cost 600 yuan, which means that at least a few hundred million people will need to spend half a month's income.
would they like to? Vaccines are not a luxury, they are intended to be protected against immunity.
for a society, if the majority of people vaccinated do not reach the majority, they will not be able to be immunized, and outbreaks will still occur, with a significant impact on the economic life of society as a whole.
, according to the latest news, the relevant national level is currently exploring the possibility of centralized procurement or inclusion of vaccines in health insurance after the vaccine is centrally available by the end of the year.
how to price a new vaccine abroad: Pfizer $19.50 per dose, AstraZeneta $2.50, Johnson and Johnson $10, Moderna $50, Russian vaccine $10 international COVID-19 Vaccine Global Access Guarantee Mechanism (COVAX), an agency of the Global Alliance for Vaccine Immunization (GAVI), the Alliance for Innovation in Epidemiological Prevention (CEPI) and the World Health Organization (WHO) dedicated to promoting vaccine development and production and equitable access to new crown vaccines.
report by COVAX suggests that the new vaccine will have different prices in rich and poor countries, which can be a little higher, but a little cheaper in poor countries.
for rich countries, the maximum price per dose of vaccine should not exceed $40.
estimates, the total price of the two doses is $80, or about Rmb560.
, if China's vaccine is priced at 600 yuan and two doses, that means it's priced according to the standards of rich countries.
, however, at this price, COVAX also takes into account the "speed premium", the first vaccine developed, to get a relatively high price, which is an incentive for research and development and a mechanism for market demand.
there is a saying that America's new crown vaccine will be free.
this statement is not accurate.
In August, Pfizer and partner BioNTech (Germany) announced that they had reached a pre-purchase agreement with the U.S. Department of Health and Human Services (HHS) and the Department of Defense (DoD) to provide 100 million doses of the new crown vaccine, worth $1.95 billion.
, according to the commercial purchase contract, the price of each dose of vaccine is $19.5, which now appears to be the government's bill.
, however, is this only the wholesale price of the vaccine, is there any additional price for the transport, storage and injection of the vaccine? are unknowns.
even if the last person to get vaccinated doesn't have to pay for it himself, it's insurance and the government.
Pfizer's pricing of the new crown vaccine, referring to the current price of seasonal flu vaccines.
two doses of the vaccine cost $40, a 70% discount on the flu vaccine.
beijing, this year's self-costed influenza vaccine is the most expensive influenza virus sub-unit vaccine, 168 yuan each, the general three-price adult influenza vaccine winning price of 40 to 50 yuan.
Pfizer's vaccine candidate is BNT162, which is currently in Phase 3 clinical trials.
commercial procurement contract with the U.S. government requires at least emergency approval for the vaccine ("Emergency Use Authorization") before it can take effect.
the U.S. government won't pay a penny if clinical trials don't work.
is not the only company in the U.S. with a vaccine candidate.
a July 21 congressional hearing, Mene Pangalos, AstraZeneta's head of biopharmaceus technology research and development, said it would provide the U.S. with 300 million doses of the new crown vaccine, AZD1222, at cost.
AstraZeneta had previously signed a pre-purchase agreement with the European Alliance for Inclusive Vaccines, which would also provide 300 million doses of AZD1222, with a "no profit" price of 750 million euros, so the price per dose would be 2.50 euros.
at the hearing, Johnson and Johnson also said it would offer vaccines at cost during the new crown pandemic, after Paul Stoffels, the company's CEO, said the price of the vaccine was about $10 or 10 euros per dose.
as well as AstraZeneta and Johnson and Johnson vaccines are still in phase 3 clinical stages.
, of course, not all companies are willing to offer vaccines at cost.
, which is based in the U.S., says it is currently conducting clinical trials of the RNA vaccine, which will cost $50 to $60 per dose in the future.
the price of China's new crown vaccine? Will the Chinese be vaccinated for free? The inactivated vaccine has been urgently approved by the Uae, but the country has not announced a price.
from the general pricing operation analysis, the domestic pricing of the vaccine group will also affect the pricing overseas, if the domestic pricing is too low, it is not possible to provide higher prices overseas.
russia has officially approved its own adenovirus vector vaccine after completing only Phase 2 of the clinic.
not yet announced a domestic price, but said it would offer it to other countries for $10.
It should be pointed out that the above-mentioned vaccines in the United States, the United Kingdom, Russia, are not inactivated vaccines, RNA vaccines and adenovirus vaccines, the production process does not require new coronavirus, and China's inactivated vaccine production process is more complex, the need to enlarge the culture of live viruses, production costs and the cost of maintaining biosecurity should be higher than other vaccines, it is not possible to as AstraZenelan's adenovirus vector vaccine, the cost of 2.50 euros per dose.
of $10 to $20 should be achievable.
the Internet before the rumor that the price of two inactivated vaccines is 1000 yuan.
from 1000 yuan to the current 600 yuan, inactivated vaccine prices have eddy in close to international prices, but there is still a gap.
to be honest, even with the out-of-pocket price of 168 yuan for the flu vaccine as a reference, there will still be a large proportion of Chinese people who do not want to pay for their own new crown vaccine.
Bold guess, to solve the problem of vaccine prices, perhaps only once again asked the state to sell, at a price of about 100 yuan a dose of centralized procurement, and then through health insurance to pay part or even most of the costs, in order to promote vaccination on a large scale.
, preventive vaccines have not been included in the Essential Health Insurance Drug List since 1 September this year.
given that there is little current outbreak in China, there is no urgent need for vaccines, and there may be another way: wait.
now gives vaccine companies more flexibility in commercial pricing, allowing them to offer vaccines at reasonable prices to more urgently needed international markets, while some of the country's most in-need people can get injections at their own expense.
If clinical trials go well, several vaccines will be approved in countries by the end of the year, and after the first wave is met, the international price of vaccines will fall next year, when the price of centralized procurement can be lower, and the burden on countries and health care will be greatly reduced.
china's ability to contain the outbreak has come at a great cost and should reasonably receive some of the dividends it deserves.
, no matter how the vaccine is priced, the premise is to get approval first.
.